ArticleCureus2025
Phenotyping Chronic Obstructive Pulmonary Disease Through Principal Component Analysis: Identification of Clinical Clusters.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition with varied clinical presentations and prognoses. Identifying patient phenotypes is essential for developing personalized treatment strategies. Principal component analysis (PCA) is a statistical method that can be employed to uncover clinical clusters and gain insight into the relationships among different disease characteristics. This study aims to analyze COPD patient phenotypes using PCA and to identify the key clinical features influencing their distribution. Materials and methods This was a prospective, observational outpatient study involving 96 patients diagnosed with COPD. Data collected included demographic, clinical, spirometric, echocardiographic, laboratory, and functional parameters. PCA was applied to reduce data dimensionality and to identify the principal components underlying phenotype structure. Results The first two principal components accounted for 62% of the total variance, underscoring the clinical heterogeneity of COPD. Visualization of the PCA revealed four distinct clusters that align with recognized COPD phenotypes: chronic bronchitis, emphysema, COPD with asthmatic features (previously referred to as asthma-COPD overlap), and the non-exacerbator type. Each cluster was associated with specific clinical characteristics. Conclusions PCA enabled the identification of four distinct clinical clusters among COPD patients: bronchitis, emphysema, COPD with asthmatic features, and non-exacerbator. This approach helps clarify the relationship between clinical characteristics and supports a more personalized approach to treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.